Meeting Program
14:00 Welcome and presentation of the course: aims, expectations, and a brief look back
14:30-17:30: Red Cell and Consultative
Chair: Irene Roberts
14:30-15:15: Subarna Chakravorty, Kings College: Difficult management problems in sickle cell disease
15:15-16:00: Antonis Kattamis, Athens: Transfusional iron overload – why does it matter and how do we treat it?
16:00-16:30: Coffee break
16:30-17:15: Anne Kelly, GOSH: Investigation and management of difficult bleeding and thrombosis cases in pediatrics
18:00-19:00: Evening Lecture
Irene Roberts: Neonatal hematology – a Sherlock Holmes approach
8:30-9:00: What did you learn yesterday?
Re-cap by participants – coordinated by Anna Avagyan
9:00-12:30: Bone Marrow Failure and Cytopenia
Chair: Arndt Borkhardt
9:00-9:45: Carlo Dufour, Genoa: Classical and new forms of neutropenia in children and adults
9:45-10:30: John Grainger, Manchester: Challenges in childhood immune thrombocytopenia
10:30-11:00: Coffee break
11:00-11:45: Thierry Leblanc, Paris: Fanconi Anemia, a pleiotropic disease (title might change)
11:45-12:30: Cases from participants: Mystery cytopenias and how to solve them
14:00-17:30: Lymphomas and Histiocytosis
Chair: Josef Vormoor
14:00-16:00 pm: The pediatric EHA FORUM: the experts reply to the young investigators
Online (if possible) for EHA: A. Attarbaschi: NHL: challenging cases (T-cell, Burkitt, DLBCL, ALCL)
16:00-16:30: Coffee break
16:30-17:15: J. Donadieu: Langerhans and Non Langerhans Histiocytosis
18:00-19:00: Evening Lecture
Bruno and Roberta Matera: Eat, drink, and enjoy – Local geology, Italian food and wine
8:30-9:00: What did you learn yesterday?
Re-cap by participants – coordinated by Anna Avagyan
9:00-12:30: Leukemia
Chair: André Baruchel
9:00-9:45: Josef. Vormoor: How leukemic cells reprogram their bone marrow micro-environment – how AI can help us to understand cell communication
9:45-10:30: Brenda Gibson: Clinical management problems in AML
10:30-11:00: Coffee break
11:00-11:45: Michel Zwaan: How to incorporate new drugs in AML
11:45-12:30: Charlotte Niemeyer: Hypercellular, hypocellular or just dysplastic? JMML and MDS
14:00-17:30: Leukemia
Chair: Andrea Biondi
14:00-14:45: Shai Izraeli: Molecular pathogenesis of childhood ALL
14:45-15:30: André Baruchel: Immunotherapy of ALL: current and future role
15:30-16:00: Coffee break
16:00-16:45: Marion Strullu: Difficult management questions in ALL (a duet – Ph+ & Infant cases to be included)
16:45-17:30: K. Schmiegelow (/potential successor): How to assess the burden of ALL Therapy?
18:00-19:00: Evening Lecture
Arndt Borkhardt: Prevention of childhood acute lymphoblastic leukemia: aspiration or pie in the sky?
8:30-9:00: What did you learn yesterday?
Re-cap by participants – coordinated by Anne Avagyan
9:00-12:30: Hematopoietic Stem Cell Transplantation
Chair: Adriana Balduzzi
9:00-9:45: Adriana Balduzzi: Novel developments in transplantation of childhood ALL
9:45-10:30: Maria Ester Bernardo: Gene-therapy for sickle cell disease and thalassemia
10:30-11:00: Coffee break
11:00-11:45: Friso Calkoen: CAR-T and beyond: case management
11:45-12:15 pm: Closing Lecture
Andrea Biondi: The changing landscape of ALL treatment: a successful journey in middle income countries
12:30 pm: End of Course